CardioKine Overview
- Year Founded
-
2004
- Status
-
Acquired/Merged
- Employees
-
17
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$150M
CardioKine General Information
Description
Developer of pharmaceutical compounds and drugs for treatment and prevention of heart failure and related cardiovascular indications.
Contact Information
Corporate Office
- 30 South 15th Street
- 15th Floor
- Philadelphia, PA 19102
- United States
Corporate Office
- 30 South 15th Street
- 15th Floor
- Philadelphia, PA 19102
- United States
CardioKine Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 04-Jan-2012 | $150M | Completed | Clinical Trials - Phase 3 | ||
| 2. Early Stage VC (Series B) | 01-May-2006 | Completed | Startup | |||
| 1. Early Stage VC (Series A) | 13-Apr-2004 | $37M | $37M | Completed | Startup |
CardioKine Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-1 | ||||||||
| Series B | ||||||||
| Series A | 37,000,000 | $0.001000 | $0.08 | $1 | $1 | 1x | $1 | 21.41% |
CardioKine Patents
CardioKine Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-6221851-B1 | Increasing cellular availability of adenosine. | Inactive | 19-Sep-1997 | ||
| AU-750688-B2 | Pharmaceutical compositions and methods for the treatment of failing myocardial tissue | Inactive | 19-Sep-1997 | ||
| AU-9573698-A | Pharmaceutical compositions and methods for the treatment of failing myocardial tissue | Active | 19-Sep-1997 | ||
| EP-1045636-A1 | Pharmaceutical compositions and methods for the treatment of failing myocardial tissue | Inactive | 19-Sep-1997 | ||
| EP-1045636-A4 | Pharmaceutical compositions and methods for the treatment of failing myocardial tissue | Inactive | 19-Sep-1997 | A61K31/7064 |
CardioKine Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
CardioKine Former Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Advent Life Sciences | Venture Capital | Minority | ||
| Advent Venture Partners | Venture Capital | Minority | ||
| Aisling Capital | Venture Capital | Minority | ||
| Burrill & Co | Merchant Banking Firm | Minority | ||
| CIBC Capital Partners | Investment Bank | Minority |
CardioKine FAQs
-
When was CardioKine founded?
CardioKine was founded in 2004.
-
Where is CardioKine headquartered?
CardioKine is headquartered in Philadelphia, PA.
-
What is the size of CardioKine?
CardioKine has 17 total employees.
-
What industry is CardioKine in?
CardioKine’s primary industry is Drug Discovery.
-
Is CardioKine a private or public company?
CardioKine is a Private company.
-
What is the current valuation of CardioKine?
The current valuation of CardioKine is .
-
What is CardioKine’s current revenue?
The current revenue for CardioKine is .
-
How much funding has CardioKine raised over time?
CardioKine has raised $87M.
-
Who are CardioKine’s investors?
Advent Life Sciences, Advent Venture Partners, Aisling Capital, Burrill & Co, and CIBC Capital Partners are 5 of 10 investors who have invested in CardioKine.
-
When was CardioKine acquired?
CardioKine was acquired on 04-Jan-2012.
-
Who acquired CardioKine?
CardioKine was acquired by Chiesi USA.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
